Surfactant-Enhanced Protein Secretion in E. coli Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant proteins in Escherichia coli, such as physical fracturing, face challenges including equipment requirements, nucleic acid contamination, toxicity, immunogenicity, limited production volume, and inefficient secretion, which hinder high-density and continuous production.
Innovation Solution
A method involving the use of a surfactant in the culture solution to facilitate the secretion of recombinant proteins by Escherichia coli, allowing for high-volume production and increased secretion efficiency, with a dried cell density of 1.5 to 500 g/L, utilizing surfactants like amphoteric, anionic, and nonionic surfactants to enhance protein secretion into the culture solution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If physical fracturing methods are used to extract protein from Escherichia coli, then protein extraction is achieved, but equipment is required and nucleic acid contamination occurs
Solution Approach 1:
The patent extracts only the necessary function (protein secretion) from the complex physical fracturing process. By using surfactants to enable natural secretion of recombinant proteins from Escherichia coli into the culture medium, the method eliminates the need for ultrasonication equipment, homogenizers, and other fracturing devices while achieving effective protein recovery without nucleic acid contamination
Solution Approach 2:
The patent introduces surfactants as intermediary substances that facilitate protein secretion. These surfactants act as mediators between the bacterial cell and the culture medium, enabling the recombinant protein to be naturally secreted without mechanical fracturing. This intermediary approach replaces complex physical equipment with a chemical facilitator that achieves the same extraction goal more simply
2Quantity of substance
If physical fracturing methods are used to extract protein from Escherichia coli, then protein extraction is achieved, but nucleic acid constituents contaminate the protein extracts
Solution Approach 1:
The patent performs preliminary action by enabling protein secretion to occur naturally during the culture process before any extraction step is needed. The surfactant-treated bacteria continuously secrete recombinant proteins into the culture medium, so the protein is already separated from the bacterial cells and nucleic acids before extraction begins, eliminating contamination at the source rather than requiring subsequent purification steps
3Quantity of substance
If physical fracturing methods are used to extract protein from Escherichia coli, then protein extraction is achieved, but a large amount of proteins derived from Escherichia coli and other impurities contaminate the protein extracts
Solution Approach 1:
The patent extracts only the recombinant protein of interest by enabling its natural secretion into the culture medium, leaving the harmful bacterial proteins and impurities inside the intact bacterial cells. This selective extraction approach retrieves only the desired protein product while excluding endotoxins, immunogenic proteins, and other contaminants that remain trapped within the bacterial cell structure
Solution Approach 2:
The surfactant acts as a selective intermediary that facilitates the export of recombinant proteins while maintaining the integrity of the bacterial cell membrane for harmful substances. The surfactant specifically promotes the secretion of secretory proteins through the Sec or TAT pathways while leaving other bacterial proteins and endotoxins confined within the cell, achieving selective purification
4Quantity of substance
If physical fracturing methods are used to extract protein from Escherichia coli, then protein extraction is achieved, but purification process is needed to isolate contaminated proteins
Solution Approach 1:
The patent performs preliminary separation by enabling natural protein secretion during the culture phase itself. By the time harvesting begins, the recombinant protein is already secreted into the culture medium and separated from bacterial cellular components, so minimal purification steps are needed compared to fracturing methods where extensive chromatography and filtration are required to remove cellular contaminants
5Quantity of substance
If physical fracturing methods are used to extract protein from Escherichia coli, then protein extraction is achieved, but accumulation of recombinant protein in Escherichia coli limits the production volume
Solution Approach 1:
The patent establishes continuous useful action by enabling ongoing protein secretion throughout the bacterial growth phase. Instead of accumulating protein intracellularly until harvest, the surfactant-treated bacteria continuously export recombinant proteins into the culture medium as they grow, allowing production to scale continuously with bacterial growth without the limitations of intracellular accumulation capacity
Solution Approach 2:
The patent uses the bacterial cell as a living factory that continuously produces and secretes protein copies into the external medium. The surfactant enables the bacteria to function as continuous production units rather than batch reactors, where each cell continuously exports protein copies to the culture medium, multiplying the effective production volume proportional to the bacterial growth
6Productivity
If Escherichia coli secretes recombinant protein in culture solution, then production volume increases, but Escherichia coli easily dies and the method does not suit for high-density or continuous production
Solution Approach 1:
The patent applies parameter changes by introducing surfactants that modify the cellular environment to enable stable protein secretion. The surfactants alter membrane properties and secretion dynamics in a controlled manner that maintains bacterial viability during high-density culture, allowing the system to achieve both high productivity and bacterial stability through optimized chemical parameters
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables high-volume production of recombinant proteins with increased secretion efficiency, easy purification, and continuous production without killing the bacteria, thereby overcoming the limitations of existing techniques.
Implementation Method 1
the culture solution contains a surfactant (A)... a method in which a bacterium secretes the useful substance in the presence of a surfactant... addition of the surfactant of the present invention in production of a useful substance (protein, etc.) utilizing a bacterium increases the production volume and the secretion amount
Data Source
AI summary
The present invention is aimed to provide a method for industrially producing a useful substance (protein etc.) utilizing a bacterium such as Escherichia coli in the presence of a surfactant and a surfactant to be used in this method for producing a useful substance. The present invention is a method for producing a useful substance into a culture solution by secretion by a bacterium in the culture solution, wherein the culture solution contains a surfactant (A), and a dried cell density based on the volume of the culture solution is 1.5 to 500 g/L. More preferably, the present invention is a method for producing a useful substance wherein the surfactant (A) is at least one agent selected from the group consisting of an amphoteric surfactant, an anionic surfactant, and a nonionic surfactant having an HLB value of 0 to 13.